Table 4. Survival analysis of different metastatic organs and treatment modalities.
| Parameter | Non-surgery (months), median (95% CI) | Surgery (months), median (95% CI) | Log Rank | P value |
|---|---|---|---|---|
| Only lung metastasis | 5.00 (4.90–5.11) | 15.00 (14.56–15.44) | 3,834.12 | <0.001 |
| Lung + liver metastasis | 2.00 (1.91–2.09) | 10.00 (9.46–10.55) | 1,548.96 | <0.001 |
| Lung + bone metastasis | 4.00 (3.86–4.14) | 10.00 (9.26–10.74) | 442.61 | <0.001 |
| Lung + brain metastasis | 3.00 (2.82–3.18) | 8.00 (6.98–9.02) | 125.80 | <0.001 |
| Chemotherapy | ||||
| Yes | 9.00 (8.87–9.13) | 24.00 (23.29–24.71) | 7,849.03 | <0.001 |
| No | 1.00 (0.97–1.03) | 9.00 (8.37–9.63) | ||
| Radiotherapy | ||||
| Yes | 6.00 (5.87–6.13) | 20.00 (18.71–21.29) | 8,923.70 | <0.001 |
| No | 3.00 (2.94–3.06) | 18.00 (17.39–18.61) |
CI, confidence interval.